Navigation Links
Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy)
Date:7/16/2014

lective goals to develop and deliver high quality biologic alternatives that address patient needs," said Ludwig Hantson, Ph.D., president of Baxter BioScience. 

About CHS-0214

CHS-0214 is a proposed biosimilar of etanercept (Enbrel®).  This product was evaluated in a Phase 1 single dose cross-over study in healthy volunteers.  In this trial, CHS-0214 met the primary bioequivalence endpoint of clinical PK similarity to Enbrel®, demonstrating a 98% geometric mean between CHS-0214 and Enbrel®.  No clinically meaningful differences in other safety parameters were observed during this study.

About Coherus BioSciences, Inc.

Coherus is a late-stage clinical biologics platform company focused on the global biosimilar market.  Headquartered in the San Francisco Bay Area and composed of a team of industry veterans with decades of experience in pioneering biologics companies, Coherus has developed an innovative business model that leverages a strategically aligned consortium of key service providers specifically crafted to address the biosimilar opportunity and to achieve competitive scale.  Coherus' commercialization partnerships include global pharmaceutical companies in Europe, Asia and Latin America.

Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and expand patient access.  For additional information, please visit www.coherus.com.

About Baxter International, Inc.

Baxter International, Inc., through its subsidiaries, develops, manufactures, and markets products that save and sustain the lives of people with hemophilia, immune disorders, cancer, infectious diseases, kidney disease,
'/>"/>

SOURCE Coherus BioSciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Coherus Announces CHS-0214 (Proposed Etanercept Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study
2. Coherus anuncia que CHS-0214 (biosimilar etanercept propuesto) supera punto final primario en decisivo estudio clínico farmacocinético
3. Coherus Biosciences als Präsentator zur J.P. Morgan Annual Healthcare Conference 2014 eingeladen
4. Coherus Biosciences Invited to Present at 2014 J.P. Morgan Annual Healthcare Conference
5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
8. Misonix Announces New Distribution Agreement For Panama
9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... ANGELES , Dec. 17, 2014  ImmunoCellular ... the US Patent and Trademark Office (USPTO) has ... ICT-107, a dendritic cell-based immunotherapeutic vaccine targeting six ... The claims of US Patent No. 8,871,211, which ... neural cancer by administering a dendritic cell composition ...
(Date:12/17/2014)... PCCA received the Autism Hope Alliance,s ... program seal for best practices in meeting needs ... practices, materials and goods that meet strict criteria ... affected by autism often have unique physical or ... found in food and medicine – for instance ...
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research and ... addition of the "Inferior Vena Cava (IVC) Filters ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... sector is projected to reach US$435 million by 2016. ... nearly 39% (2015) of the global value while ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 2Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 3Inferior Vena Cava (IVC) Filters - Global Trends, Estimates and Forecasts, 2012-2018 4
... March 2, 2011 A new ad campaign ... 2445 would raise taxes on prescription drug benefits and ... reduce health care costs for Mississippi families and businesses, ... S.B. 2445 would also put the State Board ...
... has launched a groundbreaking initiative for primary care physicians ... Health Group, Inc., is providing qualifying primary care practices ... extract usefulness out of existing clinical data at the ... practice improvement support and education. The initiative is supported ...
Cached Medicine Technology:New Ad Campaign: Secret Provision Raises Taxes on Prescription Drug Benefits, Creates 'Conflict of Interest' 2Joslin Diabetes Center Launches Initiative to Resolve the Critical Link Connecting Continuing Medical Education (CME) to Sustained Quality Improvement 2Joslin Diabetes Center Launches Initiative to Resolve the Critical Link Connecting Continuing Medical Education (CME) to Sustained Quality Improvement 3
(Date:12/17/2014)... 16, 2014 (HealthDay News) -- Expectant parents should leave ... Drug Administration recommends. Use of ultrasound imaging and ... not entirely risk-free, the agency warns. "Although ... due to ultrasound imaging and heartbeat monitors, prudent use ... important," Shahram Vaezy, an FDA biomedical engineer, said in ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. ... to improve overall health, but a growing body of evidence ... new review finds. In fact, the benefits were similar ... lead researcher Paula Chu, a doctoral candidate at Harvard University,s ... clinical trials, found that people randomly assigned to take yoga ...
(Date:12/15/2014)... 15, 2014 Veretekk.com, Inc. announced today ... Avenue. JM Ocean Avenue has secured exclusive benefit ... automated marketing system. JM Ocean Avenue is a ... of Ocean Avenue and JM International, with partial ownership ... per year company. , “After nearly 2 decades of ...
(Date:12/15/2014)... OutMarket , a provider of marketing automation ... Sheets ,” a guide that exposes the insider secrets ... top ten social media networks. , Social media ... and customer service. It can also increase new leads ... new networks and weather constantly changing algorithms, they need ...
(Date:12/15/2014)... December 15, 2014 The increase in prevalence ... of the main factors which is contributing to the growth ... the diagnosis and treatment of hearing loss and balance disorders ... three parts - microphone, speaker and amplifier. The global market ... of 6.01% during the period from 2014 to 2019. Some ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4
... ... orthodontist, Dr. Inna Gellerman, kicks off holiday season with food drives, toy drives and ... ... , Dr. Inna Gellerman, celebrates the holiday season by participating in various community events, ...
... ... Medtronic founder, joins Dr. Jean Watson to launch The Million Nurse Global ... www.millionnurseproject.org ! . Nurses are uniting to celebrate the 2010 ... and two proposed United Nations Resolutions, together to radiate heart-centered Love and ...
... , ... With over 45 million uninsured in the ... Obama’s plans for health insurance reform in the United States, one ... transcends traditional boundaries. MediBid connects physicians to patients in a free-market ...
... ... has announced that they have added a new line of Natural ... Vitamins are produced on FDA registered and inspected facility operating since ... Medicine’s Nutritional vitamins and supplements make them safe, top quality products. ...
... ... company and "Top 100" Rochester, NY Growth Company, is partnering with AstraZeneca ... for the improved management of hypertension. The partnership program positions community ... a select group of Canadian retail pharmacy participants. , ...
... , AUBURN HILLS, Mich., Dec. ... integrated logistics services and highly customized supply chain solutions ... Worldwide Holdings, Inc. The terms of the transaction are ... , Addison, IL-based NAL is a third-party logistics (3PL) ...
Cached Medicine News:Health News:Long Island Children's Orthodontist, Dr. Inna Gellerman, Celebrates Season of Giving with Holiday Drives and Events 2Health News:The Million Nurse Global Caring Field Project Launches Jan. 1st, 2010 at Noon 2Health News:MediBid.com Empowers Physicians to Expand Their Fee for Service Practice with New Online Portal 2Health News:MediBid.com Empowers Physicians to Expand Their Fee for Service Practice with New Online Portal 3Health News:All Alternative Medicine Products LLC. Presents a New Line of Natural Nutritional Supplements and Vitamins 2Health News:All Alternative Medicine Products LLC. Presents a New Line of Natural Nutritional Supplements and Vitamins 3Health News:All Alternative Medicine Products LLC. Presents a New Line of Natural Nutritional Supplements and Vitamins 4Health News:PharmaSmart International, Inc and AstraZeneca Canada Enter Into Strategic Partnership to Elevate Pharmacy Based Hypertension Management 2Health News:syncreon Acquires NAL Worldwide Holdings Inc. 2Health News:syncreon Acquires NAL Worldwide Holdings Inc. 3
Coarse abrasive for knife sharpening, 6 grams net...
Standard vice clamp, can be fitted instead of Quick Realease Cassette...
... sectioning work, it is necessary to cool a ... can be fitted to most microtomes and will ... lower, depending on conditions. The equipment consists of ... cooling stage is best suited for operation with ...
... a new type of freezer designed to rapidly ... a rapid freezer tank which can hold object ... the specimens. ,The Clini-RF eliminates the need to ... and liquid nitrogen. In order to save power, ...
Medicine Products: